FDAnews
www.fdanews.com/articles/158622-cubist-recalls-antibiotic-after-finding-glass-particles

Cubist Recalls Antibiotic After Finding Glass Particles

September 13, 2013
Cubist Pharmaceuticals voluntarily recalled four lots of its blockbuster antibiotic Cubicin after glass particles turned up in some vials in those lots. The Lexington, Mass., drugmaker stressed that there have been no adverse events related to the recall, which was announced on Thursday. Still, glass particles can be a potential safety hazard for patients, Cubist said.
Drug Industry Daily